Colonic stenting or surgery in left-sided colonic obstruction for disseminated incurable colorectal cancer: a multicenter randomised trial

ISRCTN ISRCTN01790428
DOI https://doi.org/10.1186/ISRCTN01790428
Secondary identifying numbers 1206
Submission date
20/12/2005
Registration date
20/12/2005
Last edited
15/07/2021
Recruitment status
Stopped
Overall study status
Stopped
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Study website

Contact information

Dr Jeanin van Hooft
Scientific

Afd. Maag-, Darm- en Leverziekten, C2-220
Academisch Medisch Centrum
P.O. Box 22660
Amsterdam
1105 AZ
Netherlands

Phone +31 (0)63 002 3579
Email info@stent-in.nl

Study information

Study designMulticentre, randomised, active controlled, parallel group trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleColonic stenting or surgery in left-sided colonic obstruction for disseminated incurable colorectal cancer: a multicenter randomised trial
Study acronymStent-in I study
Study objectives1. Patients with incurable disseminated left-sided colonic cancer are better palliated by colonic stenting than surgery, measured by hospital free survival in "good health" (World Health Organization [WHO] score 0 or 1)
2. Colonic stenting is cost effective in patients with incurable disseminated left-sided colonic cancer
Ethics approval(s)Ethics approval received from the local medical ethics committee
Health condition(s) or problem(s) studiedColonic cancer
InterventionSurgical palliation versus "wait and see" policy and colonic stenting if obstruction is imminent.
Intervention typeOther
Primary outcome measure1. Total hospital free survival in good health (corrected for days with a WHO performance status greater than 1)
2. Integral costs (product of volume consumed care and prices of means (personnel, overhead, material and investments)
Secondary outcome measures1. Procedural related hospital stay and mortality and morbidity
2. Efficacy of palliation of (imminent) obstruction (complaints, secondary operation or stent placement)
3. Quality of life
Overall study start date01/12/2004
Completion date01/01/2008
Reason abandoned (if study stopped)Objectives no longer viable

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants180
Total final enrolment21
Key inclusion criteria1. Left sided colonic cancer (from left flexure to greater than 10 cm of anus)
2. Diagnosis histological proven
3. No signs of double tumour
4. Informed consent
Key exclusion criteria1. Potentially curable disease
2. American Society of Anaesthesiologists (ASA) IV or V
3. Ileus
4. Karnofsky index of less than 50%
Date of first enrolment01/12/2004
Date of final enrolment01/01/2008

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Afd. Maag-, Darm- en Leverziekten, C2-220
Amsterdam
1105 AZ
Netherlands

Sponsor information

Academic Medical Centre (AMC) (Netherlands)
Hospital/treatment centre

Department of Obstetrics and Gynaecology
Meibergdreef 9
Amsterdam
1105 AZ
Netherlands

Website http://www.amc.uva.nl/
ROR logo "ROR" https://ror.org/03t4gr691

Funders

Funder type

Research organisation

The Netherlands Organization for Health Research and Development (ZonMw) (The Netherlands)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article premature closure results 04/11/2006 15/07/2021 Yes No

Editorial Notes

15/07/2021: The trial was stopped due to a high number of serious adverse events. Publication reference and total final enrolment added.